NCT00549055 A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life. Status COMPLETED Phase N/A
NCT00548262 This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis Status COMPLETED Phase PHASE4
NCT00548093 PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib Status COMPLETED Phase PHASE2
NCT00547560 Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population Status COMPLETED Phase PHASE1
NCT00545129 A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone Status COMPLETED Phase PHASE2
NCT00544557 Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis Status COMPLETED Phase N/A
NCT00543439 Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII Status COMPLETED Phase PHASE3
NCT00542685 A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder Status COMPLETED Phase PHASE3
NCT00542035 A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction Status COMPLETED Phase PHASE2
NCT00542009 A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight Status COMPLETED Phase PHASE2
NCT00541606 Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes Status COMPLETED Phase NA
NCT00537615 An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT00535379 SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme Status UNKNOWN Phase PHASE2
NCT00533455 Gabapentin for the Treatment of Neuroleptic-Induced Tremor Status TERMINATED Phase PHASE3